肺炎支原体肺炎与预后相关的临床指标
收稿日期: 2022-01-27
网络出版日期: 2022-04-07
Clinical indicators related to prognosis of Mycoplasma pneumoniae pneumonia
Received date: 2022-01-27
Online published: 2022-04-07
刘峰 . 肺炎支原体肺炎与预后相关的临床指标[J]. 临床儿科杂志, 2022 , 40(4) : 247 -251 . DOI: 10.12372/jcp.2022.22e0170
Mycoplasma pneumoniae (MP) results in community-acquired pneumonia in children by causing direct damage and immune damage to respiratory tissue. At present, refractory Mycoplasma pneumoniae pneumonia (RMPP), MPP complications such as bronchial mucous plugs, bronchiolitis obliterans, etc., have increased significantly. Therefore, it is very important to grasp the clinical indicators for the prediction and diagnosis of RMPP and MPP-related complications for the prognosis of childhood diseases.
Key words: Mycoplasma pneumoniae pneumonia; prediction; clinical indicator; child
[1] | Ding Y, Chu C, Li Y, et al. High expression of HMGB1 in children with refractory Mycoplasma pneumoniae pneumonia[J]. BMC Infect Dis, 2018, 18:439. |
[2] | Meyer Sauteur PM, van Rossum AM, Vink C. Mycoplasma pneumoniae in children: carriage, pathogenesis, and antibiotic resistance[J]. Curr Opin Infect Dis, 2014, 27(3):220-227. |
[3] | Jiang ZL, Li SH, Zhu CM, et al, Mycoplasma pneumoniae infections: pathogenesis and vaccine development[J]. Pathogens, 2021, 10(2):119. |
[4] | Tamura A, Matsubara K, Tanaka T, et al. Methyl-prednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children[J]. J Infect, 2008, 57(3):223-228. |
[5] | 卢志威, 赵辉, 郑跃杰, 等. 三种方法对儿童肺炎支原体感染诊断的动态评价[J]. 临床儿科杂志, 2012, 30(4):382-385. |
[6] | Zhu Y, Wang J. Logistic regression analysis of high risk factors of mycoplasma pneumoniae pneumonia in children[J]. Hebei Med, 2018, 24:60-63. |
[7] | Qu BN, Chi L, Zhu ZW, et al. Clinical characteristics and high risk factors of mycoplasma pneumoniae pneumonia in children[J]. Chin Pediatr Integrated Traditi Western Med, 2019, 11:58-62. |
[8] | Liu XM, Cui ZZ, Yang G, et al. Analysis of risk factors of Mycoplasma pneumoniae pneumonia[J]. China J Modern Med, 2019, 10:1-8. |
[9] | Gong Hui, Sun Baijun, Chen Ye, et al. The risk factors of children acquiring refractory mycoplasma pneumoniae pneumonia: a meta-analysis[J]. Medicine (Baltimore), 2021, 100:e24894. |
[10] | Liu XF, Zhao ZM, Zhang ZP, et al. Analysis of risk factors of Mycoplasma pneumoniae pneumonia in children[J]. Hebei Med, 2017, 23:780-783. |
[11] | Zhou YA. Changes of C-reactive protein in the course of mycoplasma pneumonia and its clinical significance[J]. Chin J Misdiagnosis, 2011, 11:3567-3569. |
[12] | Wen J, Su Y, Sun H, et al. The combination of initial markers to predict refractory Mycoplasma pneumoniae pneumonia in Chinese children: a case control study[J]. Respir Res, 2021, 22(1):89. |
[13] | Yuan SJ, Xie HT, Li ZL. Clinical significance of hypersensitive C-reactive protein, fribrinogen and D-dimmer in connective tissue disease-related interstitial lung disease[J]. Nan Fang Yi Ke Da Xue Xue Bao, 2017, 37:415-419. |
[14] | Kazama I, Nakajima T. Acute bronchitis caused by bordetella pertussis possibly co-infected with Mycoplasma Pneumoniae[J]. Am J Case Rep, 2019, 20:60-64. |
[15] | Tezol O, Bozlu G, Sagcan F, et al. Value of neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, platelet-to-lymphocyte ratio and red blood cell distribution width in distinguishing between reactive lymphadenopathy and lymphoma in children[J]. Bratisl Lek Listy, 2020, 121:287-292. |
[16] | Balta S, Demirkol S, Kucuk U. The platelet lymphocyte ratio may be useful inflammatory indicator in clinical practice[J]. Hemodial Int, 2013, 17:668-669. |
[17] | Patel N, Penkert RR, Jones BG, et al. Baseline serum vitamin A and D levels determine benefit of oral vitamin A&D supplements to humoral immune responses following pediatric influenza vaccination[J]. Viruses, 2019, 11(10):907. |
[18] | Ling Y, Ning J, Xu Y. Explore the predictive value of peripheral blood cell parameters in refractory mycoplasma pneumoniae pneumonia in children over 6 years old[J]. Front Pediatr, 2021, 9:659677. |
[19] | Huang X, Li D, Liu F, et al. Clinical significance of D-dimer levels in refractory Mycoplasma pneumoniae pneumonia[J]. BMC Infectious Diseases, 2021, 21(1):14. |
[20] | Jain S, Williams DJ, Arnold SR, et al. Community-acquired pneumonia requiring hospitalization among U.S. children[J]. N Engl J Med, 2015, 372(9):835-845. |
[21] | Gao LW, Yin J, Hu YH, et al. The epidemiology of paediatric Mycoplasma pneumoniae pneumonia in North China: 2006 to 2016[J]. Epidemiol Infect, 2019, 147:e192. |
[22] | Zhang Y, Zhou Y, Li S, et al. The clinical characteristics and predictors of refractory Mycoplasma pneumoniae pneumonia in children[J]. PLoS One, 2016, 11(5):e0156465. |
[23] | Bi Y, Zhu Y, Ma X, et al. Development of a scale for early prediction of refractory Mycoplasma pneumoniae pneumonia in hospitalized children[J]. Sci Rep, 2021, 11(1):6595. |
[24] | Zhao Q, Zhang T, Zhu B, et al. Increasing age affected polymorphonuclear neutrophils in prognosis of Myco-plasma pneumoniae pneumonia[J]. J Inflamm Res, 2021, 14:3933-3943. |
[25] | Daxboeck F, Gattringer R, Mustafa S, et al. Elevated serum alanine aminotransferase (ALT) levels in patients with serologically verified Mycoplasma pneumoniae pneumonia[J]. Clin Microbiol Infect, 2010, 11(6):507-510. |
[26] | Xu Q, Zhang L, Hao C, et al. Prediction of bronchial mucus plugs formation in patients with refractory Mycoplasma pneumoniae pneumonia[J]. J Trop Pediatr, 2017, 63(2):148-154. |
[27] | Xu X, Li H, Sheng Y, et al. Nomogram for prediction of bronchial mucus plugs in children with Mycoplasma pneumoniae pneumonia[J]. Sci Rep, 2020, 10(1):4579. |
[28] | Smeijsters KMG, Bijkerk RM, Daniels JMA, et al. Effect of bronchoscopy on gas exchange and respiratory mechanics in critically ill patients with atelectasis: an observational cohort study[J]. Front Med, 2018, 5:301. |
[29] | Kavaliunaite E, Aurora P. Diagnosing and managing bronchiolitis obliterans in children[J]. Expert Rev Respir Med, 2019, 13(5):481-488. |
[30] | Cheng Q, Zhang H, Shang Y, et al. Clinical features and risk factors analysis of bronchitis obliterans due to refractory Mycoplasma pneumoniae pneumonia in children: a nomogram prediction model[J]. BMC Infect Dis, 2021, 21(1):1085. |
/
〈 |
|
〉 |